Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Astellas, Astrazeneca, Biogen, Curevac Swiss, Cytodyn, Eli Lilly, Glaxosmithkline, Janssen, Kintor, Lintonpharm, Mayne, Mithra, Moleac, RDIF, Seagen, Shenzhen Chipscreen, Vir.